Learn More
PURPOSE Vascular endothelial growth factor (VEGF) is a potent molecule that mediates tumor angiogenesis primarily through VEGF receptor 2 (VEGFR2). Bevacizumab, a recombinant humanized monoclonal antibody to VEGF, was administered to previously untreated patients to evaluate parameters of angiogenesis. PATIENTS AND METHODS Twenty-one patients with(More)
STUDY OBJECTIVE We describe the epidemiology of emergency department (ED) visits for attempted suicide and self-inflicted injury. METHODS Data were obtained from the National Hospital Ambulatory Medical Care Survey, a national probability sample of ED visits. All visits for attempted suicide or self-inflicted injury (E950 to E959) during 1997 to 2001 were(More)
OBJECTIVES To estimate the prevalence of complementary and alternative medicine (CAM) usage among emergency department (ED) patients. METHODS This study was a cross-sectional study in four Boston-area EDs. For two 24-hour periods, the authors interviewed consecutive patients age 18 and older about whether they had ever used or had recently (within the(More)
Arpi Doshi, BA Edwin D. Boudreaux, PhD Nan Wang, BS Andrea J. Pelletier, MS, MPH Carlos A. Camargo Jr., MD, DrPH From the University of Michigan Medical School, Ann Arbor, MI (Doshi); Departments of Emergency Medicine and Psychiatry, Cooper Hospital and University of Medicine and Dentistry of New Jersey–Robert Wood Johnson Medical School, Camden, NJ(More)
  • 1